Abstract
Purpose
We retrospectively evaluated blood culture (BC) isolates of coagulase-negative staphylococci other than Staphylococcus epidermidis (NonSe-CoNS) for clinical relevance at a tertiary care hospital in Germany from January 2011 to September 2015.
Methods
Clinical data were correlated to microbiological results based on medical records. Infection was considered likely if (1) no other infection and (2) two or more isolates of the same species were present and (3) symptoms ameliorated after therapy. Infection was considered possible if a foreign body was present and (1) and (3) were fulfilled. All the other cases were considered contaminations.
Results
313 patients with blood cultures positive for NonSe-CoNS were identified. 61 patients were excluded, either because of missing data or multiple pathogens in the same blood culture. Of the remaining 252 patients, 58 (23 %) were classified as possible (n = 32) or likely (n = 26) infections. S. haemolyticus was the most frequent isolate (infection: n = 28), followed by S. hominis (n = 13), S. capitis (n = 12), and S. lugdunensis (n = 3). One patient died from NonSe-CoNS infection. The source of infection in the majority of patients was foreign bodies (n = 43), and endocarditis was present in six cases. Staphylococci always considered contaminations were: S. auricularis, S. caprae, S. schleiferi, S. pettenkoferi, S. saccharolyticus, and S. simulans. The growth of NonSe-CoNS in the anaerobic BC bottle only and a time to positivity >36 h were associated with contaminations.
Conclusions
One out of four NonSe-CoNS isolates was clinically relevant in our cohort, where S. haemolyticus, S. capitis, S. hominis, and S. lugdunensis contributed to 96.6 % of all relevant infections.
Similar content being viewed by others
References
Becker K, Heilmann C, Peters G. Coagulase-negative staphylococci. Clin Microbiol Rev. 2014;27:870–926. doi:10.1128/CMR.00109-13.
von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis. 2002;2:677–85.
Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32(Suppl 2):S114–32. doi:10.1086/320184.
Piette A, Verschraegen G. Role of coagulase-negative staphylococci in human disease. Vet Microbiol. 2009;134:45–54. doi:10.1016/j.vetmic.2008.09.009.
Gatermann SG, Koschinski T, Friedrich S. Distribution and expression of macrolide resistance genes in coagulase-negative staphylococci. Clin Microbiol Infect. 2007;13:777–81. doi:10.1111/j.1469-0691.2007.01749.x.
Farrag N, Lee P, Gunney R, Viagappan GM. Staphylococcus lugdunensis endocarditis. Postgrad Med J. 2001;77:259–60.
Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ. Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis. 1993;17:871–6.
Jones RM, Jackson MA, Ong C, Lofland GK. Endocarditis caused by Staphylococcus lugdunensis. Pediatr Infect Dis J. 2002;21:265–8.
Ebright JR, Penugonda N, Brown W. Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis. Diagn Microbiol Infect Dis. 2004;48:17–21. doi:10.1016/j.diagmicrobio.2003.08.008.
Ziegler MJ, Pellegrini DC, Safdar N. Attributable mortality of central line associated bloodstream infection: systematic review and meta-analysis. Infection. 2015;43:29–36. doi:10.1007/s15010-014-0689-y.
Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;49:1–45. doi:10.1086/599376.
Fadel HJ, Patel R, Vetter EA, Baddour LM. Clinical significance of a single Staphylococcus lugdunensis-positive blood culture. J Clin Microbiol. 2011;49:1697–9. doi:10.1128/JCM.02058-10.
Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R. Non- epidermidis coagulase-negative staphylococcal bacteremia: clinical predictors of true bacteremia. Eur J Clin Microbiol Infect Dis. 2004;23:495–8. doi:10.1007/s10096-004-1134-4.
Haimi-Cohen Y, Shafinoori S, Tucci V, Rubin LG. Use of incubation time to detection in BACTEC 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures. Pediatr Infect Dis J. 2003;22:968–74. doi:10.1097/01.inf.0000095195.60494.ba.
Garcia-Vazquez E, Fernandez-Rufete A, Hernandez-Torres A, Canteras M, Ruiz J, Gomez J. When is coagulase-negative Staphylococcus bacteraemia clinically significant? Scand J Infect Dis. 2013;45:664–71. doi:10.3109/00365548.2013.797599.
Kirchhoff LV, Sheagren JN. Epidemiology and clinical significance of blood cultures positive for coagulase-negative Staphylococcus. Infect Control. 1985;6:479–86.
Kim SD, McDonald LC, Jarvis WR, McAllister SK, Jerris R, Carson LA, Miller JM. Determining the significance of coagulase-negative staphylococci isolated from blood cultures at a community 14 hospital: a role for species and strain identification. Infect Control Hosp Epidemiol. 2000;21:213–7. doi:10.1086/501747.
Herwaldt LA, Geiss M, Kao C, Pfaller MA. The positive predictive value of isolating coagulase-negative staphylococci from blood cultures. Clin Infect Dis. 1996;22:14–20.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings-Duke endocarditis service. Am J Med. 1994;96:200–9.
Chu VH, Cabell CH, Abrutyn E, Corey GR, Hoen B, Miro JM, et al. Native valve endocarditis due to coagulase-negative staphylococci: report of 99 episodes from the international collaboration on endocarditis merged database. Clin Infect Dis. 2004;39:1527–30. doi:10.1086/424878.
Falcone M, Campanile F, Giannella M, Borbone S, Stefani S, Venditti M. Staphylococcus haemolyticus endocarditis: clinical and microbiologic analysis of 4 cases. Diagn Microbiol Infect Dis. 2007;57:325–31. doi:10.1016/j.diagmicrobio.2006.08.019.
Czekaj T, Ciszewski M, Szewczyk EM. Staphylococcus haemolyticus—an emerging threat in the twilight of antibiotics age. Microbiology. 2015;. doi:10.1099/mic.0.000178.
Bhatt P, Tandel K, Singh A, Mugunthan M, Grover N, Sahni AK. Species distribution and antimicrobial resistance pattern of coagulase-negative staphylococci at a tertiary care centre. Med J Armed Forces India. 2016;72:71–4. doi:10.1016/j.mjafi.2014.12.007.
Zinkernagel AS, Zinkernagel MS, Elzi MV, Genoni M, Gubler J, Zbinden R, Mueller NJ. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection. 2008;36:314–21. doi:10.1007/s15010-008-7287-9.
Sabe MA, Shrestha NK, Gordon S, Menon V. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative Staphylococcus infective endocarditis. Eur Heart J Acute Cardiovasc Care. 2014;3:275–80. doi:10.1177/2048872614523350.
Sato M, Kubota N, Horiuchi A, Kasai M, Minami K, Matsui H. Frequency, clinical manifestations, and outcomes of Staphylococcus lugdunensis bacteremia in children. J Infect Chemother. 2016;. doi:10.1016/j.jiac.2016.01.012.
Zhang Q, Li D, Bai C, Zhang W, Zheng S, Zhang P, Zhang S. Clinical prognostic factors for time to positivity in cancer patients with bloodstream infections. Infection. 2016;. doi:10.1007/s15010-016-0890-2.
Lim SJ, Choi JY, Lee SJ, Cho YJ, Jeong YY, Kim HC, et al. Intensive care unit-acquired blood stream infections: a 5-year retrospective analysis of a single tertiary care hospital in Korea. Infection. 2014;42:875–81. doi:10.1007/s15010-014-0651-z.
Aimoto M, Koh H, Katayama T, Okamura H, Yoshimura T, Koh S, et al. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia. Infection. 2014;42:971–9. doi:10.1007/s15010-014-0657-6.
Kamath U, Singer C, Isenberg HD. Clinical significance of Staphylococcus warneri bacteremia. J Clin Microbiol. 1992;30:261–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Hitzenbichler, F., Simon, M., Salzberger, B. et al. Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital. Infection 45, 179–186 (2017). https://doi.org/10.1007/s15010-016-0945-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-016-0945-4